OR7E115P

Across TCGA pan-cancer cohorts, OR7E115P RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated OR7E115P data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher OR7E115P RNA is associated with better overall survival. In most high-consensus cancer types, elevated OR7E115P expression acts as an unfavorable survival marker, although some lineages such as HNSC and SKCM show a favorable association.

HNSC, SKCM, and LIHC are the cancer types where OR7E115P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Median	All	0.764	0.637	.003	99	view →
SKCM	OS	Tertile	All	0.508	0.280	<.001	81	view →
LIHC	DFS	Tertile	II,III,IV	0.557	0.374	.005	35	view →
UVM	DFS	Tertile	III,IV	0.120	0.747	.001	33	view →
CESC	OS	Tertile	All	0.880	0.743	.004	28	view →
BLCA	DFS	Median	IV	0.494	0.247	.024	19	view →
LUSC	OS	Quartile	II,III,IV	0.405	0.739	.008	18	view →
ESCA	DFS	Median	III,IV	0.470	0.226	.004	17	view →
UCS	DFS	Tertile	III,IV	0.689	0.341	.029	12	view →
MESO	OS	Tertile	II,III,IV	0.774	0.497	.027	12	view →
LAML	DFS	Tertile	All	0.238	0.471	.013	10	view →
STAD	OS	Tertile	IV	0.682	0.197	.023	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

OR7E115P–HNSC (OS)

Open the HNSC breakdown →